Transforming skincare with cutting-edge science.
A rigorously tested innovation in skincare.
ReyaGel has undergone extensive safety and clinical testing to be FDA-cleared as a medical device for use in a wide variety of clinical settings.
ReyaGel is FDA-cleared for the management of wounds including:
Post-laser surgery
Surgical wounds: donor sites / grafts, post-Moh’s surgery
Partial and full-thickness wounds
Trauma wounds: abrasions, lacerations, and skin tears
Tunneled / undermined wounds
Podiatric, wound dehiscence
Pressure, diabetic, and venous ulcers
Second degree burns
Carefully designed to repair & restore.
Tissue regeneration is a complex process involving multiple phases to restore healthy skin. Each phase requires a number of different biomolecules. There is no single “magic ingredient” for optimal healing results. ReyaGel was developed to offer a powerful blend of biomolecules - carefully selected to help the skin rejuvenate and heal.
MTP® is desgined from the extracellular matrix (ECM) of multiple tissue types, containing a wide variety of natural biomolecules vital to the healing process, including:
Exosomes
Collagen Types I, III, IV, V
Laminin
Elastin
Fibronectin
Fibroblast Growth Factor (FGF)
Vascular Endothelial Growth Factor (VEGF)
Epidermal Growth Factor (EGF)
Hyaluronic Acid
Repair. Remodel. Reduce redness & pain.
In the early phases of healing, inflammation (redness and swelling) is how the body prevents infection as it brings in the materials and cell types it needs to repair itself. The extracellular matrix contains not only a wealth of those materials the body needs to heal and regenerate, but also key biomolecules that help the body move out of the inflammatory phase and into a positive tissue remodeling phase to restore new, healthy skin.
How MTP works.
Supplements the body with concentrated biomaterials missing from damaged or aged skin.
Components of MTP provide the constituents to reconstruct a variety of tissues within the body, including blood vessels and lymphatic channels, often overlooked in large volumetric tissue regeneration.
MTP components induce the body’s own regenerative capabilities by recruiting stem, progenitor, and immune cell types to the site of application to shift the body’s inflammatory response to a regenerative response, including angiogenesis.
